Looking forward to seeing you at #WCLC2021!! If anyone else is interested in Antibody–Drug Conjugates in #lungcancer, Please come to the education session ES04 at @WCLC2021 on Sep 10.

youtu.be/K7Dt3fs542U

Repotrectinib data presented by Byoung Chul Cho, M.D., Ph.D. . #ena2022 #ROS1

On National Lung Cancer Screening Day, I would like to thank and support the efforts of Byoung Chul Cho Byoung Chul Cho, M.D., Ph.D. & his study -Novel drug for #LungCancer showing promise in early-stage clinical trials Marjorie Zettler PhD, MPH Learn how Qure.ai is working for the cause. #RSNA22

Byoung Chul Cho, M.D., Ph.D. nicely overviewed antibody-drug conjugates (ADCs), bispecific antibodies. T-DXd, Dato-DXd, HER3-DXd, Teliso-V, Amivantamab, and Tarlatamab, etc. #LCSM #TASLC

Today, we presented new preclinical #data supporting intracranial activity of NVL-655 at #AACR23. Thank you to our collaborators Dr. Cho Byoung Chul Cho, M.D., Ph.D. and his group at Yonsei University College of Medicine. bit.ly/3opryDI